pocketful logo light
pocketful logo light
Lactose (India) Ltd logo

Lactose (India) Ltd

NSE: BSE: 524202

₹127.75

(5.19%)

Mon, 25 May 2026, 05:18 pm

mtf coin illustrationMTF 5x

Lactose (India) Analysis

dividend

thumbs up icon

Pros

    thumbs up icon

    Cons

    • Unable to evaluate Lactose (India)'s dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
    • Unable to evaluate Lactose (India)'s dividend against the top 25% market benchmark as the company has not reported any payouts.

    health

    thumbs up icon

    Pros

    • Lactose (India) is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
    • Lactose (India) has been profitable on average in the past, therefore cash runway is not a concern.
    • Lactose (India) has been profitable on average in the past, therefore cash runway is not a concern.
    • The level of debt compared to net worth has been reduced over the past 5 years (242.1% vs 111.9% today).
    thumbs up icon

    Cons

    • Debt is not well covered by operating cash flow (5%, less than 20% of total debt).
    • Debt is not covered by short term assets, assets are 0.6x debt.
    • Lactose (India)'s long term commitments exceed its cash and other short term assets.
    • Lactose (India) is making a loss, therefore interest payments are not well covered by earnings.
    • Lactose (India)'s level of debt (111.9%) compared to net worth is high (greater than 40%).
    • High level of physical assets or inventory.

    management

    thumbs up icon

    Pros

    • The tenure for the Lactose (India) board of directors is about average.
    • The tenure for the Lactose (India) management team is about average.
    thumbs up icon

    Cons

    • Atul's remuneration is higher than average for companies of similar size in India.
    • Atul's compensation has increased whilst company is loss making.

    misc

    thumbs up icon

    Pros

      thumbs up icon

      Cons

      • Lactose (India) is not covered by any analysts.

      past

      thumbs up icon

      Pros

        thumbs up icon

        Cons

        • Unable to compare Lactose (India)'s 1-year earnings growth to the 5-year average as it is not currently profitable.
        • Lactose (India) does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
        • Lactose (India) used its assets less efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
        • It is difficult to establish if Lactose (India) improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
        • It is difficult to establish if Lactose (India) has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
        • Unable to compare Lactose (India)'s 1-year growth to the IN Pharmaceuticals industry average as it is not currently profitable.

        value

        thumbs up icon

        Pros

        • Lactose (India) is good value based on assets compared to the IN Pharmaceuticals industry average.
        thumbs up icon

        Cons

        • Lactose (India) is loss making, we can't compare its value to the IN Pharmaceuticals industry average.
        • Lactose (India) is loss making, we can't compare the value of its earnings to the India market.
        • 524202 underperformed the Pharmaceuticals industry which returned 26.7% over the past year.
        • 524202 underperformed the Market in India which returned -14.5% over the past year.
        • BSE:524202 is flat (-0.3%) underperforming the Pharmaceuticals industry which returned 6.8% over the past month.
        • BSE:524202 is flat (-0.3%) underperforming the market in India which returned 8% over the past month.